Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

63.30
Delayed Data
As of 4:00pm ET
 +0.73 / +1.17%
Today’s Change
47.97
Today|||52-Week Range
64.00
+19.84%
Year-to-Date
Gilead Sciences Stock Downgraded: 3 Things You Need to Know
2:28pm / MotleyFool.com - Paid Partner Content
Wall Street Sells Off on Worries Over Clinton-Trump Showdown
Sep 26 / TheStreet.com - Paid Partner Content
Investors Reward Merck Despite Flat Revenue Growth
Sep 27 / GuruFocus News - Paid Partner Content
Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies
Sep 26 / TheStreet.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know
Sep 27 / MotleyFool.com - Paid Partner Content
Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?
Sep 26 / MotleyFool.com - Paid Partner Content
Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.
Sep 27 / Zacks.com - Paid Partner Content
Takeover Chatter Around Clovis May Be Overdone
Sep 23 / TheStreet.com - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
BioLineRx Begins Trial on BL-8040/ Keytruda Combination
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close62.57
Today’s open63.00
Day’s range62.50 - 63.48
Volume11,782,741
Average volume (3 months)9,496,852
Market cap$173.0B
Dividend yield2.91%
Data as of 4:00pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+4.31%
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-7.92%
P/E ratio34.8
Price/Sales3.87
Price/Book3.90

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.34+0.42%
PFEPfizer+0.16+0.47%
GSKGlaxoSmithKline+0.35+0.81%
ABBVAbbVie-0.35-0.54%
Data as of 4:02pm ET, 09/28/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.98
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Search for Jobs